500 related articles for article (PubMed ID: 28380308)
1. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Rare
Ortega VE; Li X; O'Neal WK; Lackey L; Ampleford E; Hawkins GA; Grayeski PJ; Laederach A; Barjaktarevic I; Barr RG; Cooper C; Couper D; Han MK; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Peters SP; Pirozzi C; Rennard SI; Woodruff PG; Hoffman EA; Meyers DA; Bleecker ER;
Am J Respir Crit Care Med; 2020 Mar; 201(5):540-554. PubMed ID: 31661293
[No Abstract] [Full Text] [Related]
3. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
[TBL] [Abstract][Full Text] [Related]
4. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
[TBL] [Abstract][Full Text] [Related]
6. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
[TBL] [Abstract][Full Text] [Related]
7. A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height.
North TL; Ben-Shlomo Y; Cooper C; Deary IJ; Gallacher J; Kivimaki M; Kumari M; Martin RM; Pattie A; Sayer AA; Starr JM; Wong A; Kuh D; Rodriguez S; Day IN
J Med Genet; 2016 Apr; 53(4):280-8. PubMed ID: 26831755
[TBL] [Abstract][Full Text] [Related]
8. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
Ghosh AJ; Hobbs BD; Moll M; Saferali A; Boueiz A; Yun JH; Sciurba F; Barwick L; Limper AH; Flaherty K; Criner G; Brown KK; Wise R; Martinez FJ; Lomas D; Castaldi PJ; Carey VJ; DeMeo DL; Cho MH; Silverman EK; Hersh CP;
Am J Respir Crit Care Med; 2022 Feb; 205(3):313-323. PubMed ID: 34762809
[No Abstract] [Full Text] [Related]
10. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
11. Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline.
Mehta AJ; Thun GA; Imboden M; Ferrarotti I; Keidel D; Künzli N; Kromhout H; Miedinger D; Phuleria H; Rochat T; Russi EW; Schindler C; Schwartz J; Vermeulen R; Luisetti M; Probst-Hensch N;
Occup Environ Med; 2014 Apr; 71(4):234-40. PubMed ID: 24213563
[TBL] [Abstract][Full Text] [Related]
12. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
13. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort.
Thun GA; Ferrarotti I; Imboden M; Rochat T; Gerbase M; Kronenberg F; Bridevaux PO; Zemp E; Zorzetto M; Ottaviani S; Russi EW; Luisetti M; Probst-Hensch NM
PLoS One; 2012; 7(8):e42728. PubMed ID: 22912729
[TBL] [Abstract][Full Text] [Related]
14. Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study.
Parker MM; Foreman MG; Abel HJ; Mathias RA; Hetmanski JB; Crapo JD; Silverman EK; Beaty TH;
Genet Epidemiol; 2014 Nov; 38(7):652-9. PubMed ID: 25112515
[TBL] [Abstract][Full Text] [Related]
15. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects.
Malerba M; Ricciardolo F; Radaeli A; Torregiani C; Ceriani L; Mori E; Bontempelli M; Tantucci C; Grassi V
Thorax; 2006 Feb; 61(2):129-33. PubMed ID: 16284217
[TBL] [Abstract][Full Text] [Related]
16. α-1 Antitrypsin Genotype-Phenotype Discrepancy in a 42-Year-Old Man Who Carries the Null-Allele.
Pavičić T; Ćelap I; Njegovan M; Tešija Kuna A; Štefanović M
Lab Med; 2020 May; 51(3):301-305. PubMed ID: 31583408
[TBL] [Abstract][Full Text] [Related]
17. Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study.
Regan EA; Lowe ME; Make BJ; Curtis JL; Chen QG; Cho MH; Crooks JL; Lowe KE; Wilson C; O'Brien JK; Oates GR; Baldomero AK; Kinney GL; Young KA; Diaz AA; Bhatt SP; McCormack MC; Hansel NN; Kim V; Richmond NE; Westney GE; Foreman MG; Conrad DJ; DeMeo DL; Hoth KF; Amaza H; Balasubramanian A; Kallet J; Watts S; Hanania NA; Hokanson J; Beaty TH; Crapo JD; Silverman EK; Casaburi R; Wise R
J Gen Intern Med; 2023 Oct; 38(13):2988-2997. PubMed ID: 37072532
[TBL] [Abstract][Full Text] [Related]
18. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
19. Genome-wide association study of lung function and clinical implication in heavy smokers.
Li X; Ortega VE; Ampleford EJ; Graham Barr R; Christenson SA; Cooper CB; Couper D; Dransfield MT; Han MLK; Hansel NN; Hoffman EA; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Woodruff PG; Hawkins GA; Bleecker ER; Meyers DA;
BMC Med Genet; 2018 Aug; 19(1):134. PubMed ID: 30068317
[TBL] [Abstract][Full Text] [Related]
20. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.
Al Ashry HS; Strange C
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
